Biostock interview with CEO Peter Egelberg

June 11, 2018
Language flag

Interview with CEO Peter Egelberg (Swedish) on biostock.se where he talks about PHI’s progress, where PHI is right now and where PHI wants to be in the near future.

“Our goal is to be top of mind when researchers and scientists worldwide are looking for a new cell analytic tool”.

You find the interview here.

Latest News

Directed issue registered at the Companies Registration Office

PHI Board of Directors’ proposal on a directed issue to Altium S.A. was resolved on the extraordinary general meeting on November 15, 2023. The directed issue has now been registered at the Swedish Companies Registration Office.

Bulletin from extraordinary general meeting in Phase Holographic Imaging PHI AB (publ) 15 november 2023

Phase Holographic Imaging PHI AB (publ) held an extraordinary general meeting on November 15, 2023. The following resolutions were passed at the meeting.
BioStock-PHI-CEO-reflects-on-the-company-momentum

BioStock: PHI’s CEO reflects on the Company’s momentum

BioStock reached out to PHI’s CEO, Patrik Eschricht, to delve into what latest developments have contributed to the heightened enthusiasm surrounding the company.
See All News